Edmonton / Guelph / Washington DC / Mississauga / Laurent / Dueren / Nashville / Toronto / Richmond / Durham / St. Louis / Knoxville / /
Company
Mallinckrodt / Bioscan Inc. / Millipore / Sigma Aldrich / Hospira Healthcare Corp. / mCi / Mandel Scientific Company Inc. / MACHEREY-NAGEL GmbH & Co. KG / GE Healthcare / Rotem Industries Ltd / ABX GmbH / /
Country
Germany / United States / Canada / /
Event
FDA Phase / /
Facility
Vanderbilt University / Edmonton PET Center / Cross Cancer Institute / University of Alberta / /
IndustryTerm
crude reaction product / gas flow / clinical applications / molecular imaging methodologies / functional imaging / chemical contaminations / final product solution / molecular imaging / imaging / disease management / non-invasive molecular imaging technologies / functional molecular imaging / energy metabolism / no-carrier / chemical purity / /
MedicalCondition
post-therapy inflammation / primary breast cancer / sterility / human cancers / PR negative breast cancer / axillary lymph node metastasis / human breast cancer / breast cancer Vincent Bouvet1 / breast cancer / residual tumor / tumor / cancer / tumors / disease / recurrent cancer / FDG silent breast cancer / metabolic syndrome / inflammatory lesions / breast tumors / GLUT5 Introduction Breast cancer / /
Canadian Breast Cancer Foundation / Canadian Council on Animal Care / Food and Drug Administration’s Radioactive Drug Research Committee / Cross Cancer Institute / University of Alberta / Edmonton PET Center / Vanderbilt University / FDA / /
Person
Brendan J. Trayner / Blake Lazurko / John Wilson / Monica Wang / David Clendening / /
Position
dose calibrator / Representative / /
Product
sodium acetate / Sterile water for injection / isoflurane / sterile water / estradiol / Tracerlab FXFN ASU / acetic acid / The HPLC injection / FDF / /
Am J Nucl Med Mol Imaging 2014;4(3):[removed]www.ajnmmi.us /ISSN:[removed]ajnmmi1401006 Original Article Automated synthesis and dosimetry of 6-deoxy-6-[18F]fluoro-D-fructose (6-[18F]FDF): a